💰Supplemental Awards Announced for Sickle Cell Disease Programs
Sickle Cell Disease Newborn Screening Follow-Up Program
Summary
HRSA will provide $65,500 in supplemental award funds to each of the 25 Sickle Cell Disease (SCD) Newborn Screening Follow-Up Program (NBS FP) grantees under HRSA-21-036 in fiscal year (FY) 2025, totaling $1,637,500. The FY 2025 supplemental funds will support grant activities that are in scope of program goals and objectives. The supplemental funding can support activities related to: increasing access to medical and support services, particularly during the pediatric to adult transition period; improving data systems; increasing workforce training and knowledge; expanding quality improvement projects; or conducting outreach to help identify individuals living with SCD who have been lost to follow-up. These activities will strengthen the linkage of individuals with SCD to appropriate and ongoing care to improve health outcomes.
Agencies
- Health and Human Services Department
- Health Resources and Services Administration
Business Impact
$$$ - High
The announcement of supplemental awards totaling $1,637,500 for Sickle Cell Disease programs indicates financial assistance opportunities for organizations engaged in healthcare services, particularly those focusing on SCD. The funding encourages business owners in healthcare to enhance service access, improve workforce knowledge, and develop data systems, aligning activities with grant objectives.